PAIGE SHABRO: Open Payments
NPI 1902335847 · VIRGINIA BCH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$282 in 14 payments from 11 companies in 2025. Trend: 2023 $484 · 2024 $317 · 2025 $282
Food & beverage: $282
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $50 |
| Janssen Pharmaceuticals, Inc | 2 | $44 |
| Corium, LLC | 1 | $25 |
| Collegium Pharmaceutical, Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| TMS NeuroHealth Centers Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Lilly USA, LLC | 1 | $15 |
Products named: VRAYLAR, SPRAVATO, Azstarys, Jornay PM, TRINTELLIX, TMS NeuroHealth Centers Inc., REXULTI, Auvelity.
Industry payments across VA — which companies pay providers there.
